Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. - Wikidata - wikimedia - TriplyDB

Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities.

Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities.

http://www.wikidata.org/entity/Q38002002

about

Developing Biosensors in Developing Countries: South Africa as a Case Study Mathematical Modelling and Tuberculosis: Advances in Diagnostics and Novel Therapies Extensively drug-resistant tuberculosis: epidemiology and management Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis Tuberculosis: epidemiology and control Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel.Cost-effectiveness comparison of Genechip and conventional drug susceptibility test for detecting multidrug-resistant tuberculosis in China Locked Nucleic Acid Probe-Based Real-Time PCR Assay for the Rapid Detection of Rifampin-Resistant Mycobacterium tuberculosis High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study.Acoustofluidic Transfer of Inflammatory Cells from Human Sputum Samples Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia Cytotoxic response persists in subjects treated for tuberculosis decades ago.The Bandim TBscore--reliability, further development, and evaluation of potential uses.Serological diagnostic assays for HIV-associated tuberculosis in sub-Saharan Africa?Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations.Current trends and newer concepts on diagnosis, management and prevention of respiratory tract infections.'Cough officer' nurses in a general medical clinic successfully detect drug-susceptible and -resistant tuberculosis.Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology.Identification of mycobacteria from solid and liquid media by matrix-assisted laser desorption ionization-time of flight mass spectrometry in the clinical laboratory Host targeted activity of pyrazinamide in Mycobacterium tuberculosis infection Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia.The discovery and identification of a candidate proteomic biomarker of active tuberculosis A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis miRNA signatures in sera of patients with active pulmonary tuberculosis Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis.Mycobacterial skin and soft tissue infection.Temporal Expression of Peripheral Blood Leukocyte Biomarkers in a Macaca fascicularis Infection Model of Tuberculosis; Comparison with Human Datasets and Analysis with Parametric/Non-parametric Tools for Improved Diagnostic Biomarker Identification Rapid implementation of new TB diagnostic tests: is it too soon for a global roll-out of Xpert MTB/RIF?Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.RETROSPECTIVE STUDY OF MEASURING TUBERCULOSIS THERAPY COMPLIANCE: GREECE AS A HOST COUNTRY FOR VULNERABLE POPULATIONS BEFORE AND DURING THE FINANCIAL CRISIS The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis.Validation of Mycobacterium tuberculosis Rv1681 protein as a diagnostic marker of active pulmonary tuberculosis Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test A metabolic biosignature of early response to anti-tuberculosis treatment.Tuberculosis screening in high human immunodeficiency virus prevalence settings: turning promise into reality.Interferon-Gamma Release Assay Performance of Cerebrospinal Fluid and Peripheral Blood in Tuberculous Meningitis in China.Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis.Economic evaluations of point of care testing strategies for active tuberculosis.Emerging technologies in point-of-care molecular diagnostics for resource-limited settings.Infections Caused by Mycobacterium tuberculosis in Recipients of Hematopoietic Stem Cell Transplantation.

P2860

Q26768606-5A2A7C6D-A560-4563-BFBD-1F48F747FD85 Q26778117-42C93982-1574-4193-922B-C95E5A794CFA Q26830094-DDFB2BCF-1088-4931-9242-4ACD772FA999 Q26849399-99696830-BCB9-4115-8AFB-ABF853FA4F7B Q27021104-9577F2AD-8C69-44B3-97BD-ABD27E6E03C0 Q27690864-3FD13D2D-FDF2-42AA-A443-141807F15CA3 Q28534773-F047A68E-0030-4E28-BF86-6BDFD7AAC83B Q28551104-7766804E-0660-4FF3-8F8C-9052C224B1AE Q30061805-5C2F34E3-8D7B-4711-9B7D-350201BFC4EB Q30354554-CDFC8D40-822E-4BD4-B4CE-77511BEAEE6C Q33593613-9AB209B6-E2C0-4EE4-912F-210BB9BBEA33 Q33644223-7D11D862-993C-42C9-B271-333D3C29C670 Q33655933-C66CAD1D-0115-4C9F-8D75-22D6BF6F0D4B Q33743476-61122E9F-20E2-4F47-9827-406A5EB9032A Q34395434-CF2E2521-DEE8-422B-A18F-634627F18B4B Q34465180-BD5A0393-6D46-4BE8-9A66-6CF00D92287D Q34482248-9555FA3A-3AC9-4639-AEDD-336FEB245567 Q34653849-D60CB94A-BF81-4790-8AC9-68FEC7DB0CB6 Q34785115-088879D2-0DBD-4359-98EE-1F68D55F6EA5 Q34981779-79F03DCB-6E92-4199-980B-F80959E2C631 Q35014534-A3937FD3-9B5B-43B1-8E17-CCD18FD49308 Q35028192-7F64AE57-D286-46F7-9F6F-9C9D5ABDBDCB Q35042658-509F45CE-8051-40E7-8F75-C00B5DF9B9B0 Q35053468-BE932B2C-97F2-4254-B11A-427C4C3A42CB Q35069484-7925AB32-7345-4DB4-82D0-A8474F36BADE Q35359858-4F4F3934-0DE2-4BFB-9342-A10284C30946 Q36030652-0AC28A7D-93C6-4305-8181-3D1699FCE8E5 Q36149564-254F1CB7-330D-4160-9E69-0D0EF96DED55 Q36159840-197E2FBA-6765-4A12-ABA4-6CE9B79C4B65 Q36264545-84D4D1DD-0BFB-45C5-BD65-108049BF84A3 Q36675409-10CE49EA-9BC0-4207-B259-9AA42675BFC3 Q36826688-495CDD5A-6B5D-455D-8697-3AC21D17B8FD Q36833723-C52AB9BA-4DAE-41ED-87A1-095333322D51 Q37569320-90437FCB-26E0-4CB9-AA1A-F8C707AE7836 Q37664997-01CEE8DC-64FE-4E5A-860F-7B89FFA24B34 Q37681568-35887E86-FB91-4148-9359-F98419A411FB Q37682208-BE13594F-39C0-4070-8804-5154F5429F52 Q38114142-F9E16C60-A565-4EA9-BC8E-745936E35F9E Q38208407-302B7326-4D64-4762-B3E8-6DEDA622D9BE Q38248018-581B2E3A-5BFB-478F-BB9F-DD9184047C28

P2860

Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities.

http://www.wikidata.org/entity/Q38002002

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Tuberculosis diagnostics and b ...... t advances, and opportunities.

@en

type

label

Tuberculosis diagnostics and b ...... t advances, and opportunities.

@en

prefLabel

Tuberculosis diagnostics and b ...... t advances, and opportunities.

@en

P1433

Q38002002-7953287C-BEF6-4412-B500-69C56CA57A19

P1476

Q38002002-96286B9B-9FB2-4783-B1B1-2ECBAAA7B47B

P2093

Q38002002-19BC71C7-B727-4E77-AD2C-B5D9D5D714F7

Q38002002-346E28E1-0F63-4ADB-B193-588A753EB335

Q38002002-4E132F7D-8F84-4ABC-B686-73B43DA09F46

Q38002002-4FCDE075-7B1D-4BA9-9F53-5A5873721BEA

Q38002002-5B88AD8D-71CE-4D45-AE4B-8810D6BD9BD6

Q38002002-91251BDC-1B35-42DA-8A3E-7A6DF2E5727C

Q38002002-B9CFEB4E-1DA9-43A2-8B62-DAAA09C62597

Q38002002-BB88EBD3-A531-4B14-88AB-03F7B6C42DB5

Q38002002-C6CA907A-7B47-4837-838A-884A5715BBC1

Q38002002-C7469022-FD79-4BEB-8656-A605B7166914

P2860

Q38002002-019EE242-0370-4564-A648-228825960288

Q38002002-06342E7C-AC67-4672-B10F-3AD5AF6DB3AD

Q38002002-0883971E-7192-42A8-B2D4-661D783235F6

Q38002002-0ACB2863-A325-430A-A08B-F84DD514BE7A

Q38002002-0E42B680-7EE1-456F-8C91-5F47682CDB32

Q38002002-0F7C19D1-7807-4DC7-9079-0FDFE6D55490

Q38002002-11196EC4-DB71-4BF8-AC37-D4298874633C

Q38002002-1CD20497-2796-4D03-B99F-FD1625C7D763

Q38002002-256B282E-8487-49AA-8481-7E8B4A2C45A8

Q38002002-2D6E91CF-5092-475E-879A-67F952E0246C

P304

Q38002002-832285E7-42EE-4895-9523-0B5BA3C6772B

P31

Q38002002-2FA11EAD-1787-4B03-80AA-756E82F8F10E

P356

Q38002002-9822C584-7C31-4C67-B895-6DBDF83505D8

P407

Q38002002-8275B459-90FC-46A9-97AB-FB3E68DA5380

P478

Q38002002-3A5243A6-EFF7-4A92-BF80-60D1D77D940E

P50

Q38002002-09C2B421-632D-4D6B-A780-1D465F6B2D13

Q38002002-0B613B41-CB71-4F6F-9786-E48FB0C01C4A

Q38002002-324A39BE-D38A-4DD7-A923-82AF1D026925

Q38002002-33A0A3C0-2ACB-47E0-A10B-1CA775E80997

Q38002002-35350BFE-11BA-4398-A709-9BD831FC5429

Q38002002-3B11D9C0-6276-451E-98CD-4D5AA35AAA34

Q38002002-51EAD146-C885-4A1A-B2AB-92EFEE1E6EF6

Q38002002-5FFDC16E-2B0B-4260-90BB-C402243392D3

Q38002002-6DC15107-4AF6-4C86-A1D6-4BF365041310

Q38002002-8827155F-D85C-4345-872B-E315097E7B9C

P577

Q38002002-284539B4-57AF-409E-8DC8-1736089C79FF

P5875

Q38002002-00AFCC4D-F5C8-4E21-A727-93F5B0CA236C

P698

Q38002002-A8F2FE22-59F2-4C6D-85A1-24398E7571C5

P921

Q38002002-4A73AC3E-340F-46C4-B3B9-13BE3A9D4704

Q38002002-EF159CB7-DCD5-4707-9D75-5B9BDD7AFCF8

P356

P1433

The Journal of Infectious Diseases

P1476

Tuberculosis diagnostics and b ...... t advances, and opportunities.

@en

P2093

Ben Marais

http://www.w3.org/2001/XMLSchema#string

Giovanni-Batista Migliori

http://www.w3.org/2001/XMLSchema#string

Jeremiah Chakaya

http://www.w3.org/2001/XMLSchema#string

Karin Weyer

http://www.w3.org/2001/XMLSchema#string

Lucica Ditui

http://www.w3.org/2001/XMLSchema#string

Marco Schito

http://www.w3.org/2001/XMLSchema#string

Martina Casenghi

http://www.w3.org/2001/XMLSchema#string

Michel Pletschette

http://www.w3.org/2001/XMLSchema#string

Nathan Ford

http://www.w3.org/2001/XMLSchema#string

Peter S Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance

Interferon- release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis

Microscopic-observation drug-susceptibility assay for the diagnosis of TB

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

Rapid molecular detection of tuberculosis and rifampin resistance

Infectious diseases biobanking as a catalyst towards personalized medicine: Mycobacterium tuberculosis paradigm.

Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis

Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection.

P304

S147-58

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIR860

http://www.w3.org/2001/XMLSchema#string

P407

P478

205 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P50

Soumya Swaminathan

Martin Peter Grobusch

Ibrahim Abubakar

Timothy D. McHugh

Alexandre Harari

P577

2012-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223977620

http://www.w3.org/2001/XMLSchema#string

P698

22496353

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde